FDMT vs MAR · rev $37.0K vs P/E 32, rev $26.19B
4D Molecular Therapeutics Inc (FDMT) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
FDMT currently screens at market cap $518.1M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the FDMT and MAR stock pages for the full models.
Not investment advice.